pargyline has been researched along with Central Nervous System Diseases in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, J | 1 |
| Piantadosi, CA | 1 |
1 other study available for pargyline and Central Nervous System Diseases
| Article | Year |
|---|---|
Prevention of H2O2 generation by monoamine oxidase protects against CNS O2 toxicity.
Topics: Amitrole; Animals; Brain; Brain Chemistry; Catalase; Catecholamines; Central Nervous System Diseases | 1991 |